Home » Topics » BioWorld Science

BioWorld Science
RSS

Enrollment complete for phase II trial of lisofylline in AML

May 22, 1997

North American Vaccine cleared to initiate trials of meningitis vaccine

May 22, 1997

Phase I results with Isis antisense anticancer drug reported at ASCO

May 22, 1997

Malononitrilamides associated with potent immunosuppressive effects in animal models

May 22, 1997

Pharmacyclics reports phase I results for Lu-Tex

May 22, 1997

FDA reschedules review date for Heart Laser

May 22, 1997

Interim results with Pharmacyclics' Gd-Tex reported at ASCO

May 22, 1997

Encouraging results reported for ImClone's lead cancer therapeutic agent

May 22, 1997

Preliminary phase II and phase I/II results for Allovectin-7

May 22, 1997

UR-12670 effective in rat model of endotoxic shock

May 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...